Devyser Diagnostics Q4: A robust quarter for the overlooked high-performer - Redeye

Redeye is positive to Devyser’s Q4 report as the company continues to deliver well on its key metrics and demonstrates a progress in line with its financial targets. Sales came in line, and OPEX was overall in check compared to our estimates. We lower our WACC based on a review of Redeye Quality Rating and update our fair value range accordingly.

Länk till analysen i sin helhet: https://www.redeye.se/research/882601/devyser-diagnostics-q4-a-robust-quarter-for-the-overlooked-high-performer?utm_source=finwire&utm_medium=RSS